BioLineRx (BLRX) EBT Margin (2018 - 2026)
BioLineRx's EBT Margin came in at -1099.66% for the quarter ended Jun 30, 2026, down 594.07 percentage points from -505.59% a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) EBT Margin (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioLineRx reported EBT Margin of -829.20%, down 793.55 percentage points year-over-year; for the year ended Dec 31, 2025, it was -639.24%, down 606.69 percentage points from the prior year.
- Going back by year, EBT Margin was -32.54% in the year ended Dec 31, 2024 (+914.48 pp) and -947.02% in the year ended Dec 31, 2023.
- The five-year range for quarterly EBT Margin is -1444.85% (the quarter ended Dec 31, 2025) to 3.33% (the quarter ended Dec 31, 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | -4.34% |
| 10 | BioLineRx | 8.30 Mn | -68.22 Mn | 235,000.00 | -1,241.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,241.16% |
| Dec 31, 2025 | -2,764.43% |
| Sep 30, 2025 | -357.38% |
| Jun 30, 2025 | -687.17% |
| Mar 31, 2025 | -657.65% |
| Dec 31, 2024 | -151.90% |
| Sep 30, 2024 | -67.33% |
| Jun 30, 2024 | -135.79% |
| Mar 31, 2024 | -48.55% |
| Sep 30, 2021 | -1,789.09% |
| Mar 31, 2021 | -1,283.93% |
| Sep 30, 2020 | -677.36% |
| Mar 31, 2020 | -1,372.49% |
| Sep 30, 2019 | -709.79% |
| Mar 31, 2019 | -818.80% |
| Sep 30, 2018 | -54,972.73% |
API Access
BioLineRx EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();